CURRICULUM VITAE - GLEN N. BARBER
PRESENT ADDRESS / PHONE:
Department of Medicine
and SylvesterComprehensiveCancerCenter
The University of MiamiSchool of Medicine
Rm 511, PapanicolaouBuilding
1550 NW 10th Ave [M877]
Tel (305) 243 5914
Fax (305) 243 5885
BIRTH DATE / PLACE:
June 23, 1962 / Hartlepool, Great Britain
CITIZENSHIP:
United Kingdom
EDUCATION:
B. Sc.1984Honours Degree, Molecular Biology/Biophysics.
Biophysics Laboratories, University of Portsmouth, Hampshire, England (1981-84)
Ph.D. 1988Center for Applied Microbiology and Research (CAMR); Porton Down, Salisbury, Wiltshire, and The LondonSchool of Hygiene
and Tropical Medicine, LondonUniversity (1985-88)
RESEARCH and PROFESSIONAL EXPERIENCE:
2006-Eugenia J. Dodson Chair in Cancer Research,
SylvesterComprehensiveCancerCenter (SCCC), University of MiamiMillerSchool of Medicine (UMMSM), Miami, FL, USA.
2006-Associate Director for Basic Research,SCCC, UMMSM.
2008-Professor, Department of Medicine; UMMSM.
2004-2008Professor, Department of Microbiology and Immunology; UMMSM.
1999-2004 Associate Professor, Department of Microbiology and Immunology, UMMSM..
1995-1998Assistant Professor, Department of Microbiology and Immunology, Winship Cancer Center, Emory University, Atlanta GA, USA.
1995 Visiting Scientist, The Institute of Medical Science, The
University of Tokyo, Minato-ku, Tokyo, Japan.
1993-1995Research Assistant Professor, Department of Microbiology, University of Washington, Seattle, WA USA.
1989-1993Research Associate, Regional PrimateResearchCenter and
Department of Microbiology, University of Washington, Seattle, WA.
PUBLICATIONS:
1.Clegg J.C.S., Barber G.N., Chamberlain J. and Oram J. (1986) Expression of Lassa virus nucleocapsid gene fragments in bacteria. Med Microbiol 175: 93-95.
2.Barber G.N., Clegg J.C.S and Chamberlain J. (1987) Expression of Lassa virus nucleocapsid protein segments in bacteria: purification of high level expression products and their application to antibody detection. Gene 56: 137-144.
3.Lloyd G., Barber G.N., Clegg J.C.S. and Kelly P. (1989) Identification of Lassa fever virus infection with recombinant nucleocapsid protein antigen. Lancet Nov 89: 1222
4.Barber G.N., Clegg J.C.S. and Lloyd G. (1990) Expression of the Lassa virus nucelocapsid protein in cells infected with a recombinant baculovirus: application to diagnostic assays for Lassa virus infection. J Gen Virol 71: 19-28
5.Barber, G.N., Tomita, J., Hovanessian, A.G., Meurs, E. and Katze, M.G. (1991) Functional expression and characterization of the interferon-induced dsRNA activated P68 protein kinase from Escherichia coli. Biochem 30:10356-10361
6.Katze M.G., Wambach M., Meurs E., Hovanessian A.G., Garfinkel M. and Barber G.N. (1991) Functional expression and RNA binding analysis of the interferon-induced, dsRNA activated 68,000 Mr protein kinase in a cell-free system. Mol Cell Biol. 11:5497-5505
7.Hu, S-L., Abrams K., Barber G.N., Moran P., Zarling J.M., Morton W.R., Kuller L. and Benveniste R.E. (1992) Protection of macaques against homologous SIV infection by immunization with recombinant made SIVMne gp160. Science 255:456-459
8.Meurs E., Watanabe Y., Kadereit S., Barber G.N., Katze M.G, Chong K., Williams B.R.G., Hovanessian AG (1992) Constitutive expression of human dsRNA activated p68 kinase in murine cells mediates phosphorylation of eIF2 and partial resistance to EMC virus growth. J Virol. 66:5805-5814
9.Koromilas A.E., Roy S., Barber G.N., Katze M.G. and Sonenberg N. (1992) Malignant transformation by a mutant of the interferon inducible dsRNA dependent kinase. Science 257:1597-1832
10.Barber G.N., Tomita J, Hovanessian A.G, Meurs E, Katze M.G. (1992) Detection of protein kinase homologues and viral RNA binding domains utilizing polyclonal antiserum prepared against a baculovirus expressed dsRNA activated 68,000 dalton protein kinase. Virology. 191:670-679
11.Meurs E., Galabru J., Barber G.N., Katze M.G., Hovanessian A.G. (1993) Tumour suppressor function of the interferon-induced 68 kDa protein kinase Proc Natl Acad Sci (USA) 90:232-236.
12. Black T.L, Barber G.N., Katze M.G. (1993) Degradation of the Interferon induced 68,000 Mr protein kinase by poliovirus requires RNA. J. Virol. 67:791-800
13.Dever T.E., Chen J.J., Barber G.N., Cigan A.M., Feng L., Donahue T.F., London I., Katze M.G. and Hinnebusch A. (1993) Mammalian eIF-2 alpha kinases functionally substitute for GCN2 and stimulate GCN4 translation in yeast. Proc Natl Acad Sci (USA) 90:4616-4620.
14.Barber G.N., Wambach M., Wong M-L., Dever T.E., Hinnebusch A., and Katze M.G. (1993) Translational regulation by the interferon-induced dsRNA-activated 68kDa protein kinase. Proc Natl Acad Sci (USA) 90:4621-4625.
15. Barber G.N., Edelhoff S., Katze M.G., and Disteche C.(1993) Assignment of the interferon-inducible double-stranded RNA-dependent protein kinase to human chromosome 2P21 and mouse chromosome 17E2. Genomics. 16:765-767.
16.Hu S-L., Stallard V., Abrams K., Barber G.N., Kuller L., Langlois A.J., Morton W.R., and Benveniste R.E. (1993) Protection of vaccinia-primed macaques against SIVmne infection by combination immunization with recombinant vaccinia virus and SIVmne gp160. J. Med. Prim. 22:92-100.
17.Barber G.N., Thompson S, Lee T.-G., Strom T., Daveau A., Katze M.G. (1994) The 58KDa inhibitor of the interferon-induced dsRNA activated protein kinase (PKR) is a TPR protein with oncogenic properties. Proc Natl Acad Sci (USA) 91:4278-4282.
18. Romano PR, Green SR, Barber GN, Mathews MB, Hinnebusch AG. (1995) Structural requirements for dsRNA-binding, dimerization and activation of the human eIF-2 alpha kinase DAI in yeast. Mol. Cell. Biol. 15:365-378.
19. Rajan P, Swaminathan S, Zhu J, Cole CN, Barber GN, Tevethia MJ, Thimapaya B. (1995) A novel translational regulation function for the Simian Virus large-T antigen gene. J. of Virol. 69:785-795.
20.Barber G.N., Katze M.G., Jagus R. (1995) Molecular Mechanisms responsible for malignant transformation by regulatory and catalytic domain variants of the interferon-induced enzyme PKR J.Biol. Chem. 270:17423-17428
21. Barber G.N., Wambach M, Thompson S, Jagus R, Katze MG (1995) PKR protein Kinase mutants lacking dsRNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Mol. Cell. Biol. 15:3138-3146.
22. Polyack S., Tang N, Wambach M, Barber G.N. and Katze, M.G. (1996) The p58 cellular inhibitor complexes with the IFN-induced, dsRNA-dependent protein kinase, PKR, to regulate it’s autophosphorylation and activity. J. Biol. Chem., 271(3):1702-1707.
23.Sharp T, Moonan F., Romashko A., Barber G.N. and Jagus R. (1998) Comparative analysis of the binding of vaccinia virus K3L and E3L gene products to PKR in vitro and in vivo. Virology, 250; 302-315.
24. Abraham N, Jaramillo ML, Duncan PI, Méthot N, Icely PL, Barber G.N, Bell J.C. (1998) The murine PKR tumor supressor gene rearranged in a lymphocytic leukaemia. Experimental Cell Research.244: 394-404.
25. Balachandran S. Kim C. N., Yeh W-C., Mak T.W., Bhalla K and Barber G.N. (1998)Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. The EMBO Journal. 17 (23), 6888-6902.
26. Taylor D., Shi S.T., Romano P., Barber G.N., Lai M. (1999) Inhibition of the interferon-inducible protein kinase, PKR, by Hepatitis C virus E2 protein. Science. 285; 107-110.
27. Balachandran S., Roberts C., Compans R.W., Archer D., and Barber G.N. (2000) Interferon potentiates viral induced apoptosis through activation of the FADD/caspase-8 death signaling pathway. J. of Virol., 74; 1513-1523.
28.Heylbroek C., DeLuca C., Lin R., Balachandran S., Barber G.N., and Hiscott J. (2000) The IRF-3 transcription factor is an essential mediator of virus induced apoptosis. J. of Virol., 74 3781-3792.
29.Balachandran S., Roberts C., Pattnaik V., Archer D and Barber G.N. (2000) Essential role for the dsRNA-dependent protein kinase, PKR, in innate immunity to viral infection. Immunity 13: 129-131.
30.Balachandran S. and Barber G.N. (2000). Vesicular Stomatitis Virus, VSV, therapy of tumors. IUBMB Life50 125-138.
31.Saunders L, Jurecic, V., and Barber G.N. (2001) The 90 and 110 kDa human NFAR proteins are translated from two differentially spliced mRNAs encoded from chromosome 19p13. Genomics 71 (2).
32. Balachandran S, Porosnicu M and Barber G.N. (2001) The oncolytic activity of vesicular
stomatitis virus, VSV, is effective against tumors with aberrent p53, Ras or Myc expression
and involves the induction of apoptosis. J. of Virology 75, 3474-3479
33. Ezelle H., Balachandran S., Polyack S and Barber G.N. (2001). Analyzing the mechanisms of interferon-induced apoptosis using CrmA and hepatitis virus NS5A. Virology 281, 124-137.
34.Lin R., Genin P., Harrington W., Barber G.N. and Hiscott J. (2001) HHV-8 encoded vIRFs interferes with the IFN antiviral response by blocking IRF-3 recruitment of CBP/p300 coactivators. Oncogene 15;20(7),800-11.
35.Polyack S.J., et al., (2001) A novel mechanism of hepatitis C virus interferon resistance: Induction of expression of the CXC chemokine, IL-8, by non-strutural 5a protein. J. of Virol.75(13), 6095-6106.
36.Saunders L., Balachanadran S., Michaels R., Ford R and Barber G.N (2001). Characterization of two alternatively spliced nuclear phosphoproteins, NFAR-1 and 2 that regulate mRNA processing and interact with the interferon-induced, dsRNA-dependent protein kinase, PKR. J. of Biol Chem. 276 (34) 32300-32312.
37Toomey N., Wood C., Deyev V., Boise L., Scott D., Liu L., Podack E., Barber G.N. and Harrington W. (2001) The mechanism of interferon-targeted therapy against HHV-8 associated lymphoma involves the induction of TRAIL-mediated apoptosis. Oncogene 20(48) 7029-40.
38Fernandez M., Porosnicu M., Markovic D and Barber G.N. (2002) Genetically engineered Vesicular Stomatitis Virus in gene therapy: Application for the treatment of malignant disease. J. of Virol. 76(2) 895-904.
39. Grandvaux N, Servant MJ., tenOever B., Sen G., Balachandran S., Barber G.N., Lin R., and Hiscott J (2002) Transcriptional profiling of interferon regulatory factor 3 target genes: Direct involvement in the regulation of interferon stimulated genes. J. of Virol. 76(11) 5532-5539.
40Pataer A., Vorburger S., Barber G.N., Chada S., Mhashilkar A., Zou-yang H., Balachandran S., Roth J., Hunt K., and Swisher S. (2002) Adenoviral transfer of the melanoma differentiation association gene (Ad-mda-7) induces apoptosis of lung cancer cells via upregulation of the dsRNA-dependent protein kinase PKR. Cancer Research 62 2239-2243.
41.Vorburger SA., Pataer A, Yoshida K., Barber G.N. Ellis LM., Swisher SG and Hunt KK (2002) Role for the dsRNA activated protein kinase, PKR, in E2F-1 induced apoptosis. Oncogene 12(41); 6278-88.
42. Ezelle H., Markovic D and Barber G.N. (2002) Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector J. of Virol. 76(23); 12325-34.
43. Ghosh SK., Wood C., Biose LH., Mian AM., Deyev VV, Feuer G., Toomey NL., Shank NC., Cabral L., Barber GN. Harrington WJ. (2002) Potentiation of TRAIL-induced apoptosis inprimary effusion lymphoma through AZT-mediated inhibition of NF-KB. Blood 15;101(6) 2321-7.
44. Ogilvie VC., Wilson BJ., Nicol SM., Saunders L.R., Barber GN. And Fuller-Pace F.V. (2003) The highly related DEAD box helicases p68 and p72 exist as heterodimers in cells. Nucleic Acid Research 1;31(5) 1470-80.
45.Obuchi M, Fernendez M and Barber G.N. (2003) Development of a recombinant vesicular stomatitis virus that exploits defects in host defense, augments specific oncolytic activity J. of Virol. 77(16):8843-56.
46. Porosnicu Mand Barber G.N. (2003) Oncolytic efficacy of recombinant vesicular stomatitis virus expressing cytosine deaminsase suicide cassette Cancer Research 63(23): 8366-76.
47. Balachandran S and Barber G.N. (2004) Defective translational control facilitates vesicular stomatitis virus oncolysis. Cancer Cell 5(1): 51-65.
48. Perkins D.J and Barber G.N. (2004) Defects in translational regulation through
phosphorylation of eIF2 abrogates anti-viral activity and facilitates the malignant transformation of human cells. Molecular and Cellular Biology 24(5) 2025-40.
49. Balachandran S, Thomas J and Barber G.N. (2004) A role for FADD in innate immune signaling. Nature. 432; 401-405.
50. Faria-Waziry P, Cahraborty P, Levay A, Barber G.N. Ezelle H, Enninga J, Arana C, Van
Deursan J and Fontora B (2005) Viral disruption of the Nup98 and mrnp41/Rae1 mRNA
nuclear export pathway. Molecular Cell 17; 1-20.
51. Ghosh SK, Kurokawa M, Ramos JC, Mian AM, Toomey NL, Cabral L, Barber GN, Dittmer
D and Harrington WJ (2005) AZT inhibits NF-B and induces the Epstein-Barr virus lytic
program in Burkitt Lymphoma. Blood 106: 235-40.
52. Pataer A, Vorburger SA, Chada S, Balachandran S, Barber GN, Roth JA, Hunt KK and Swisher SG (2005) Melanoma differenatiation associated gene-7 protein physically associates with the dsRNA-dependent protein kinase, PKR. Mol Ther: 11(5)717-23.
53. GreidingerEL., Zang YJ, Jaimes K, Hogenmiller S., Nassiri M, Barber GN and Hoffman RW (2006) A murine model of mixed connective tissue disease (MCTD) induced with U1-snRNP autoantigen.Arthritis Rheum. 54(2):661-9.
54. Majid A., Shah S., Ezelle H and Barber G.N. (2006) Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.J. of Virol. 80(14):6993-7008.
55. Lin L., Su Z., Gupta P., Barber GN., Dent P, Sarkar D and Fisher PB (2006) Activation of Ras/Raf protects cells from MDA-5 induced apoptosis. Cell Death and DifferentiationNov;13(11):1982-93
56. Balachandran S, Venkataraman T, Fisher PB, Barber GN.(2007) Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of IRF-7.J Immunol. Feb 15;178(4):2429-39.
57. Goodman AG., Smith JA., Balachandran S., Korth MJ., Barber GN, Schiff LA and Katze MG (2007) P58, an eIF2 kinase inhibitor that is activated during viral infection and ER stress regulates viral mRNA translation and replication. J Virol. Mar;81(5):2221-30.
58. Venkataraman, T., M. Valdes, S. Kakuta, G. Caceres, S. Saijo,Y. Iwakura and G. N. Barber. DExD/H Box RNA Helicase LGP2 Exerts Disparate Function in Response to Infection by RNA viruses. (2007) J. Immunol.15:178,6444-55
59.Radtke, A. L, Delbridge, L.M., Balachandran, S., Barber, G.N., and O’Riordan, M. X. D. (2007) Interferon-ientndepend role for TBK1 in maintenance of vaculolar integrity during intracellular bacterial infection. PLoS Pathogens 3(3) 29.
60. Greidinger EL, Zang Y, Martinez L, Jaimes K, Nassiri M, Bejarano P, Barber GN, Hoffman RW.(2007) Differential tissue targeting of autoimmunity manifestations by autoantigen-associated Y RNAs.Arthritis Rheum. May;56(5):1589-97
61. Andrews NP., Pack CD., Vezys V., Barber GN and Lukacher AE (2007). Early virus associated bystander events effects the fitness of the CD8 T cell response to persistent virus infection. Journal of Immunology 178(11), 7276-75.
62. Diaz RM., Galvo F., Kottke T., Wongthida P., Qiao J., Thompson J., Valdez M., Barber G.N and Vile RG. (2007) Oncolytic Immunotherapy for Melanoma using Vesicular Stomatitis Virus. Cancer Research 15;67: 2840-8.
63 Sarkar D., Park ES., Barber GN. and Fisher PB (2007) Activation of dsRNA-dependent protein kinase (PKR), a new pathway by which human polynucleotide phosphorylase (hPNPase) induces apoptosis. Cancer Research 67(17):7948-53
64. Holzen UV., Raju U., Patear A., Vorburger SA., Roth JA., Barber GN., Hunt KK and Swisher SG. (2007) The dsRNA-activated protein kinase (PKR) mediates radiation resistance in mouse embryonic fibroblasts (MEFs) through NF-kB and AKT activation Clin Cancer Res.13(20):6032-9
65. Qiao J, Kottke T, Willmon C, Galivo F, Wongthida P, Diaz RM, Thompson J, Ryno P, Barber GN, Chester J, Selby P, Harrington K, Melcher A, Vile RG. (2007) Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy. Nat Med. 2008 Jan;14(1):37-44.
66. Hickman HD, Takeda K, Skon CN, Murray FR, Hensley SE, Loomis J, Barber GN, Bennink JR, Yewdell JW.(2008) Direct priming of antiviral CD8(+) T cells in the peripheral interfollicular region of lymph nodes. Nat Immunol. 2008 Jan 13;
67. Pfeifer I, Elsby R, Fernandez M., Fontoura BM., Nussenzeig DR, Martin WD and Barber GN (2008) The NFARs retain nuclear mRNA and control translation. (Proc Natl Acad Sci (USA) in press.
68. Boutros R., Valova V., Nelson A., Barber GN., Robinson PJ and Byrne JA (2007) Identification of NFAR-1 and vimentin as a novel TPD52L1 (d53)-associated protein through large scale co-immunoprecipitation (Submitted).
69.Elsby R., Reid P., Kimball SR., Pavitt GD and Barber GN (2007) The alpha subunit of eIF2B is requisite for eIF2-mediated translational suppression of VSV. (Submitted).
Review Articles. Book Chapters:
70.Barber G.N., Agy, M.B. and Katze, M.G. (1994) Regulation of viral and cellular gene expression in cells infected by animal viruses including influenza virus and human immunodeficiency virus type 1. Methods in Molecular Genetics: Molecular Virology, Vol 4. Part A, Chapter 12 Academic Press.
71. Jagus R., Joshi B and Barber G.N. (1999) PKR, Apoptosis and Cancer: Translational control and cancer. Int. J. of Biochemistry and Cell Biology. 31; 123-138.
72. Barber G.N. (2000) The Interferons and Cell Death: Guardians of the cell or accomplices
of apoptosis? Seminars in Cancer Biology Vol 10; 2 103-113.
73.Barber G.N. (2001) Host defense, Viruses and Apoptosis. Cell Death and and Differentiation, Vol 8(2) 113-26.
74. Saunders L.R and Barber G.N. (2003) The dsRNA-binding protein family: Critical roles,
diverse cellular functions. FASEB J. 17(9):961-83.
75. Barber G.N. (2004) Vesicular stomatitis virus as an oncolytic vector. Viral Immunology17(4); 516-27.
76. Barber G.N. (2005) Vesicular stomatitis virus and RNA-viruses as gene therapy vectors
(Cancer Drug Discovery and Development; Gene Therapy for Cancer; Edited by P. Dolgert,
Humana Press Inc [In Press]).
77. Balachandran S and Barber G.N. (2005) Interferon and Host Defense.Cancer Genomics and Proteomics: Methods and Protocols. (Edited by P.B. Fisher, Humana Press Inc[In Press]).
78. Barber G.N. (2005) Interferon, PKR and Apoptosis. Cell Death and Differentiation12(6)563-70.
79. Barber G.N (2005) VSV-selective replication and protein translation Oncogene21;24(52):7710-9.
80. Majid A and Barber GN (2007) VSV as a vector for HCV vaccines (in press).
INTERNATIONAL FELLOWSHIPS AND AWARDS:
Instituto Juan March de Estudios e Investigaciones Fellowship (Spain;1993)
Japanese Society for the Promotion of Science (JSPS) Long Term Invitation Fellowship
(Japan: 1995)
International Society for Interferon and Cytokine Research (ISICR)
(Geneva 1996)
SylvesterComprehensiveCancerCenter Endowed Chair, 2003-present.
Sylvester Comprehensive Cancer Outstanding Investigator, 2005
GRANTS
ACTIVE:
1.) RO1 CA86431-07. 2004-2009; $1,900,000.
PI; Role of PKR in Growth Regulation and Apoptosis.
2.) RO1 CA095924-032003-2008; $1, 800,000.
PI; Mechanisms of VSV-mediated Oncolysis.
3.) RO1 AI053670-03 2003-2008 $1,500,000.
PI;Evaluation of the immunogenicity of HCV-like particles.
4.) R21 AI0770932008-2010 $500,000.
PI; Characterization of a novel helicase in innate immunity.
5.) Pre-SPOREFlorida(Harrington): 2007-2009 $1,000,000.
PI Barber, 3rd project: VSV Oncolysis and Lymphoma.
6.) Susan G. Komen Breast Cancer Foundation 2005-2008
Mentor for Post-Doc ($100,000).
PENDING:
1.) RO1: (Barber), 2007.PI: Mechanisms of Innate Immunity. Score: 143
2.) PO1(Barber): 2007.PI: Innate immune regulation in viro-proliferative disease. Score 181.
JOURNAL REVIEWER:
NatureNature (Biotechnology).
Cancer Research (Ed Board). Nucleic Acids Research
CellOncogene
Genetics. Int. J. Cancer Research
GeneProc. Natl. Acad. Sci. USA
EMBO J.Molecular Cancer (Ed. Board).
Journal of Biological Chemistry Virology.
Journal of Virology. Virus Research
Journal of Interferon Research. Molecular and Cellular Biology.
AD HOC GRANT REVIEWER
American Cancer Society (ACS).DOD Breast cancer August 2002
NIH: HCV infection and liver disease. 2000. NIAID PO1 Virology SS 2003
Canadian Institute of Health Research. NCI-C Interferon PO1 SS 2003
Nat. Sci. Found. (NSF). NIH: Virology SS June 2002, February 2003, 2004,.
NCI-C Gene Therapy PO1 SS 2004NIH Experimental Virology SS, June 2004.
NCI-PO1 SS June 2007.ACS SS June, 2006.
UNIVERSITY SERVICE AND TEACHING:
1991, 1993Instructor/Lecturer Department of Pathobiology,
University of Washington, WA.
1993Lecturer: Department of Microbiology, Graduate seminars in Virology
University of Washington, WA.
1994Lecturer: School of Medicine, Medical student seminars in Virology University of Washington, WA.
1996-98Member, Graduate Programs in Microbiology and Molecular Genetics (MMG) and Genetics and Molecular Biology (GMB) , EmoryUniversity.
Graduate students- lectures on Viral Oncology. Medical Students- RNA viruses including retroviruses/HIV, tumor viruses. Physician Assistant- Virology.
1999-Lectures, Grad course in Micro and Immuno; Univ. of Miami School of Medicine.
Virology; Advanced course in virology, Methods in Molecular Biology, Tumor Biology, Undergrad Virology.
2003-Director, Graduate Virology, Department of Microbiology and Immunology, Univ. MiamiSchool of Med.
2003-Chair, Search committee Virology, Department of Microbiology and Immunology, University of Miami School Med.
2003-Co-Director; Viral Oncology Program, SCCC, UnivMiamiSchool Med.
2004-Promotion and Tenure Board.UnivMiamiSchool Med.
2006-Associate Director for Basic Research, SCCC, UnivMiamiSchool Med.
POST DOCTORAL ASSOCIATES.
Ingrid Pfeifer, Paula Faria (Susan Komen Breast Cancer Award). Hiroki Ishikawa. Ai Harajima.
GRADUATE STUDENTS:
Jinhee Hyun. Josh Heiber.
GRADUATES, Ph.D, FROM LAB: Siddharth Balachandran, Laura Saunders, Jason Emmanuel,Darren Perkins, Heather Ezelle. Rachel Elsby.
MENTORSHIP: Siddharth Balachandran PhD (graduate student, post-doc, Res Asst Professor- 1996-2007) Asst ProfFoxChaseCancerCenter. Juan Carlos Ramos MD (Damon Runyon Cancer Research Foundation 2007-2009).